BSEBoard Meeting3d ago · 23 Jul 2026, 04:26 pm
Hester Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/07/2026 ,inter alia, to consider and approve the unaudited standalone ....
Hester Biosciences Ltd · 524669
✦ AI SummaryResults
Hester Biosciences Ltd has scheduled a Board meeting on 30/07/2026 to consider the unaudited standalone and consolidated financial results for the quarter ended 30 June 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Hester Biosciences Ltd - 524669 - Board Meeting Intimation for Financial Results
Attachments (1)
📄pdf
Download →
c003efc7-0369-4c6d-8141-92ac5d15c669.pdf
View document text
23 July 2026
To, To,
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Exchange Plaza,
Dalal Street, Bandra - Kurla Complex,
Mumbai 400 001 Bandra (E), Mumbai 400 051
Scrip Code: 524669 Symbol: HESTERBIO
Dear Sir / Madam:
Subject: Intimation for the Board Meeting
This is to inform you that, as per Regulation 29 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 (as amended from time to time), a meeting of the Board of Directors
of the Company is scheduled to be held on Thursday, 30 July 2026, inter alia, to consider the unaudited
standalone and consolidated financial results of the Company for the quarter ended 30 June 2026.
We request you to take note of the above.
Sincerely
For Hester Biosciences Limited
Vinod Mali
Company Secretary & Compliance Officer